Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-11

Clinical Trial Update: Treating Post-Lyme Disease Syndrome With Acetogenins [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating acetogenins for treating Post-Lyme Disease Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • acetogenins (acetogenins)

Snippet

Sponsor: Optimal Health Research | Conditions: Post-Lyme Disease Syndrome (PLDS) | Phase 1, Phase 2 | Status: COMPLETED